Virtus Health share price on ice as takeover battle heats up

Virtus Health has received yet another takeover bid. Here are the details.

Multiple ASX share investors take on one another in a tug of war in a high rise building.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • Virtus Health is in a trading halt 
  • The company's shares were trading at $8.15 before the freeze 
  • BGH Capital and CapVest are competing to acquire Virtus Health 

The Virtus Health Ltd (ASX: VRT) share price is frozen today amid a bidding war for the company.

The company's shares were trading at $8.15 before grinding to a halt. In yesterday's trade, the Virtus Health share price climbed 1.37%.

Virtus Health is a fertility treatment company with operations in Australia, Ireland, Denmark, the UK, and Singapore.

Let's take a look at why the company's share price is on hold.

Bidding contest heats up

Virtus Health has entered a trading halt amid a new takeover proposal from CapVest Partners LLP.

Virtus was notified of CapVest's revised offer this morning but is still waiting on more information. CapVest first made an offer to buy the company in January.

In a statement signed by the company secretary, Virtus Health said:

The trading halt is necessary as the company has been notified this morning that CapVest Partners LLP (CapVest) intends to submit a revised proposal to Virtus but no details of the terms of that revised proposal have been provided at this time.

Accordingly, Virtus considers a trading halt to be appropriate to prevent trading in its securities taking place in an uninformed market.

CapVest is not the only company vying for Virtus Health. Just yesterday, BGH Capital proposed a revised $8 per share off-market takeover bid to Virtus shareholders.

The Virtus Board said it was considering if this bid constituted a superior proposal to that signed with CapVest. In March, Virtus signed a transaction implementation deed with CapVest on a 100% takeover proposal which valued the company at $8.25 per share.

In total, eight competing proposals have now been received by Virtus Health.

Virtus Health share price snapshot

The Virtus Health share price has surged 27% in a year and almost 19% this year to date.

The company's shares have jumped 4% in the past month, while they are climbing nearly 2% in the past week alone.

For perspective, the S&P/ASX 200 Index (ASX: XJO) has returned about 8% over the past year.

The company has a market capitalisation of about $697 million based on the current share price.

The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

Green stock market graph with a rising arrow symbolising a rising share price.
Opinions

3 ASX shares tipped to climb over 100% in 2026

Analysts expect steep gains this year.

Read more »

A doctor appears shocked as he looks through binoculars on a blue background.
Opinions

4DMedical shares crash 20% this week: Should investors cut their losses on the once-booming stock?

The shares are now down 6.61% for the year to date.

Read more »

A woman researcher holds a finger up in happiness as if making the 'number one' sign with a graphic of technological data and an orb emanating from her finger while fellow researchers work in the background.
Healthcare Shares

Top broker tips 57% upside for beaten-down Telix shares

A leading broker expects a big rebound in Telix shares in 2026.

Read more »

Research, collaboration and doctors working digital tablet, analysis and discussion of innovation cancer treatment. Healthcare, teamwork and planning by experts sharing idea and strategy for surgery.
Healthcare Shares

Here's why Anteris shares are in a trading halt today

The company is undertaking a US$300m capital raising.

Read more »

Female scientist working in a laboratory.
Healthcare Shares

Telix shares in focus as the company meets guidance

More good news from the drug developer.

Read more »

Doctor sees virtual images of the patient's x-rays on a blue background.
Healthcare Shares

What are the healthcare stocks where RBC Capital Markets thinks you can make money?

The top buys in the sector, listed.

Read more »

A sad looking scientist sitting and upset about a share price fall.
Healthcare Shares

Polynovo shares fall despite yesterday's upbeat update. Here's what investors are watching

Polynovo shares slide after a solid update as investors wait for clearer growth signals.

Read more »

Woman flexes muscles after donating blood.
Healthcare Shares

Check out this CSL share price forecast for 2026. It's hard to believe!

RBC Capital Markets thinks CSL is a bargain at current levels.

Read more »